![]() |
市场调查报告书
商品编码
1909183
弹性成像诊断市场规模、份额及成长分析(按技术、应用、最终用户和地区划分)-2026-2033年产业预测Elastography Imaging Market Size, Share, and Growth Analysis, By Technology (Ultrasound Elastography, Magnetic Resonance Elastography ), By Application (General Imaging / Radiology, Hepatology ), By End-User, By Region - Industry Forecast 2026-2033 |
||||||
全球弹性成像市场规模预计在 2024 年达到 29.1 亿美元,从 2025 年的 31.4 亿美元成长到 2033 年的 57.2 亿美元,在预测期(2026-2033 年)内复合年增长率为 7.8%。
由于对非侵入性诊断方案的需求不断增长、慢性肝病和乳癌发病率上升,以及超音波和磁振造影弹性成像技术的创新,全球弹性成像市场正经历显着增长。意识提升,以及政府的支持性政策,预计将进一步加速市场扩张。此外,新兴市场对弹性成像服务的快速接受度以及携带式成像技术的进步也推动了这一成长趋势。主要企业正在加大研发投入,以提高影像诊断的准确性并拓展其在临床环境中的应用。这些因素共同推动弹性成像市场持续成长,并扩大其在整体诊断成像技术领域的作用。
推动全球弹性成像市场发展的因素
代谢相关性脂肪肝的日益普遍促使肝臟硬度测量成为常规检查手段,因为二维剪切波弹性成像在特定阈值下展现出较高的准确性。透过将超音波引导衰减参数与剪切波资料结合,医护人员可以根据患者发生危及生命事件的风险对其进行有效分层。此外,乳房弹性成像已成为緻密型乳房筛检的有效工具,能够以高灵敏度和特异性识别恶性微钙化灶。弹性成像在肿瘤学领域的应用日益广泛,提高了其在放射科的利用率,并巩固了其作为传统切片检查的非侵入性替代方案的地位。
限制全球弹性成像诊断市场发展的因素
全球弹性成像市场面临阻碍其扩张的许多挑战。保险公司施加的限制,例如某些慢性肝病中仅针对晚期肝纤维化的承保代码,阻碍了弹性成像在筛检的广泛应用。此外,一些保险公司将非肝臟应用的弹性成像归类为研究性项目,导致心臟病学和肌肉骨骼成像等领域的报销延迟。事先核准要求增加了行政延误,进一步阻碍了这些成像方式的常规应用。此外,心臟弹性成像缺乏标准化的支付模式,阻碍了指南建议的实施,而扩大承保范围则取决于大规模研究能否证明其成本效益。
全球弹性成像诊断市场趋势
全球弹性成像市场正呈现出显着的趋势,即加速整合人工智慧 (AI) 解决方案,以提高诊断准确性和营运效率。 AI 驱动的演算法能够简化组织硬度分析,最大限度地减少医生间解读差异,并促进与临床基准相符的预测分析,尤其是在肝纤维化等领域。主要企业正在迅速推出配备 AI 功能的先进弹性成像系统,实现即时决策,从而加快检查流程并提高疾病早期检出率,尤其是在乳癌和非酒精性脂肪肝方面。 AI 技术与弹性成像的融合有望重新定义医学影像诊断的最佳实践,并改善患者的治疗效果。
Global Elastography Imaging Market size was valued at USD 2.91 Billion in 2024 and is poised to grow from USD 3.14 Billion in 2025 to USD 5.72 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).
The global elastography imaging market is experiencing significant growth driven by the rising demand for non-invasive diagnostic options, increasing prevalence of chronic liver diseases and breast cancer, and innovations in ultrasound and MRI elastography techniques. Heightened awareness among the public for early disease detection, alongside supportive government initiatives, is expected to further accelerate market expansion. Additionally, the rapid adoption of elastography services in emerging markets and advancements in portable imaging technologies are contributing to this upward trend. Key industry players are investing in research and development to improve imaging accuracy and increase its application in clinical settings. Collectively, these factors are poised to enhance the elastography market and broaden its role in diagnostic imaging as a whole.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Elastography Imaging market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Elastography Imaging Market Segments Analysis
Global Elastography Imaging Market is segmented by Technology, Application, End-User and region. Based on Technology, the market is segmented into Ultrasound Elastography and Magnetic Resonance Elastography (MRE). Based on Application, the market is segmented into General Imaging / Radiology, Hepatology (Liver / Fibrosis), Breast Imaging, Cardiology, Orthopedic & Musculoskeletal and Urology / Vascular / Others. Based on End-User, the market is segmented into Hospitals, Diagnostic Imaging Centres and Ambulatory Surgical Centres (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Elastography Imaging Market
The rising prevalence of metabolic dysfunction-associated steatotic liver disease is encouraging the routine adoption of liver stiffness measurements, as two-dimensional shear-wave elastography delivers impressive accuracy at specific cutoffs. By integrating ultrasound-guided attenuation parameters with shear-wave data, healthcare providers can effectively stratify patients based on their risk of life-threatening events. Additionally, breast elastography has emerged as a valuable tool in dense breast screening, enabling the identification of malignant microcalcifications with high sensitivity and specificity. The increasing utilization of elastography in oncology enhances equipment use in radiology suites, reinforcing its position as a preferred non-invasive alternative to traditional biopsies.
Restraints in the Global Elastography Imaging Market
The Global Elastography Imaging market faces significant challenges that hinder its expansion. Restrictions from insurance providers, such as limiting coverage for specific codes to advanced hepatic fibrosis in select chronic liver conditions, restrict broader application for screening. Moreover, some insurers classify elastography as investigational for non-liver uses, which slows down reimbursement in fields like cardiology and musculoskeletal imaging. The need for prior-authorization introduces additional administrative delays, further discouraging routine utilization of these imaging modalities. Additionally, the lack of standardized payment models for cardiac elastography creates obstacles for guideline recommendations, with coverage advancements reliant on large-scale studies that showcase cost-effectiveness.
Market Trends of the Global Elastography Imaging Market
The Global Elastography Imaging market is witnessing a significant trend towards the accelerated integration of artificial intelligence (AI) solutions, enhancing diagnostic precision and operational efficiency. AI-driven algorithms are streamlining the analysis of tissue stiffness, minimizing variability in interpretation across practitioners, and facilitating predictive analytics aligned with clinical benchmarks, particularly in areas like liver fibrosis. Major industry players are launching advanced elastography systems equipped with AI capabilities, enabling real-time decision-making that expedites examination processes and bolsters early disease detection, notably in breast cancer and non-alcoholic fatty liver disease. This convergence of AI technology and elastography is set to redefine best practices and improve patient outcomes in medical imaging.